OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Durability of Triple Combination Therapy Versus Stepwise Addition Therapy in Patients With New-Onset T2DM: 3-Year Follow-up of EDICT
Muhammad Abdul‐Ghani, Curtiss Puckett, John M. Adams, et al.
Diabetes Care (2020) Vol. 44, Iss. 2, pp. 433-439
Open Access | Times Cited: 47
Muhammad Abdul‐Ghani, Curtiss Puckett, John M. Adams, et al.
Diabetes Care (2020) Vol. 44, Iss. 2, pp. 433-439
Open Access | Times Cited: 47
Showing 26-50 of 47 citing articles:
Advances and counterpoints in type 2 diabetes. What is ready for translation into real-world practice, ahead of the guidelines
Stanley S. Schwartz, Barbara E. Corkey, James R. Gavin, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Stanley S. Schwartz, Barbara E. Corkey, James R. Gavin, et al.
BMC Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 1
Benefits of combining SGLT2 inhibitors and pioglitazone on risk of MASH in type 2 diabetes—A real‐world study
Chi‐Ho Lee, David Tak Wai Lui, Lung‐Yi Mak, et al.
Diabetes Obesity and Metabolism (2024) Vol. 27, Iss. 2, pp. 574-582
Closed Access | Times Cited: 1
Chi‐Ho Lee, David Tak Wai Lui, Lung‐Yi Mak, et al.
Diabetes Obesity and Metabolism (2024) Vol. 27, Iss. 2, pp. 574-582
Closed Access | Times Cited: 1
Tamam Abdul‐Ghani, Curtiss Puckett, Osama Migahid, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 9, pp. 1810-1818
Closed Access | Times Cited: 6
Early Glycosylated Hemoglobin Target Achievement Predicts Clinical Outcomes in Patients with Newly Diagnosed Type 2 Diabetes Mellitus
Joonyub Lee, Jae‐Hyoung Cho
Diabetes & Metabolism Journal (2021) Vol. 45, Iss. 3, pp. 337-338
Open Access | Times Cited: 7
Joonyub Lee, Jae‐Hyoung Cho
Diabetes & Metabolism Journal (2021) Vol. 45, Iss. 3, pp. 337-338
Open Access | Times Cited: 7
Insulin Secretion Predicts the Response to Antidiabetic Therapy in Patients With New-onset Diabetes
Siham Abdelgani, Curtiss Puckett, John M. Adams, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 12, pp. 3497-3504
Open Access | Times Cited: 6
Siham Abdelgani, Curtiss Puckett, John M. Adams, et al.
The Journal of Clinical Endocrinology & Metabolism (2021) Vol. 106, Iss. 12, pp. 3497-3504
Open Access | Times Cited: 6
Insulin secretion is a strong predictor for need of insulin therapy in patients with new‐onset diabetes and HbA1c of more than 10%: A post hoc analysis of the EDICT study
Siham Abdelgani, Curtiss Puckett, John M. Adams, et al.
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. 7, pp. 1631-1639
Open Access | Times Cited: 4
Siham Abdelgani, Curtiss Puckett, John M. Adams, et al.
Diabetes Obesity and Metabolism (2021) Vol. 23, Iss. 7, pp. 1631-1639
Open Access | Times Cited: 4
Achieving Remission in the Era of Clinical Inertia: What Is Preventing Us from Treating Type 2 Diabetes?
Austen Suits, Ridhi Gudoor, Jay H. Shubrook
Diabetology (2023) Vol. 4, Iss. 1, pp. 93-107
Open Access | Times Cited: 1
Austen Suits, Ridhi Gudoor, Jay H. Shubrook
Diabetology (2023) Vol. 4, Iss. 1, pp. 93-107
Open Access | Times Cited: 1
Complex metabolic–endocrine syndromes: associations with cardiovascular disease
Andrew J. Krentz
Elsevier eBooks (2023), pp. 39-81
Closed Access | Times Cited: 1
Andrew J. Krentz
Elsevier eBooks (2023), pp. 39-81
Closed Access | Times Cited: 1
Perfecting the Puzzle of Pathophysiology: Exploring Combination Therapy in the Treatment of Type 2 Diabetes
Ridhi Gudoor, Austen Suits, Jay H. Shubrook
Diabetology (2023) Vol. 4, Iss. 3, pp. 379-392
Open Access | Times Cited: 1
Ridhi Gudoor, Austen Suits, Jay H. Shubrook
Diabetology (2023) Vol. 4, Iss. 3, pp. 379-392
Open Access | Times Cited: 1
Treatment adherence and the contemporary approach to treating type 2 diabetes mellitus
Bela Kolarš, Ivana Minaković, Beáta Grabovac, et al.
Biomedical Papers (2024) Vol. 168, Iss. 2, pp. 97-104
Open Access
Bela Kolarš, Ivana Minaković, Beáta Grabovac, et al.
Biomedical Papers (2024) Vol. 168, Iss. 2, pp. 97-104
Open Access
Gluco-regulation & type 2 diabetes: entrenched misconceptions updated to new governing principles for gold standard management
Stanley S. Schwartz, Mary E. Herman
Frontiers in Endocrinology (2024) Vol. 15
Open Access
Stanley S. Schwartz, Mary E. Herman
Frontiers in Endocrinology (2024) Vol. 15
Open Access
Two-Year Therapeutic Efficacy and Safety of Initial Triple Combination of Metformin, Sitagliptin, and Empagliflozin in Drug-Naïve Type 2 Diabetes Mellitus Patients (Diabetes Metab J 2024;48:253-64)
Young-Hwan Park, Minji Sohn, Soo Lim
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 5, pp. 1012-1013
Closed Access
Young-Hwan Park, Minji Sohn, Soo Lim
Diabetes & Metabolism Journal (2024) Vol. 48, Iss. 5, pp. 1012-1013
Closed Access
Prospects for the convergence of polyphenols with pharmaceutical drugs in Type 2 Diabetes: challenges, risks, and strategies
Swetha Reddy Allamreddy, Meenakshi Arora, Raghu Ganugula, et al.
Pharmacological Reviews (2024) Vol. 77, Iss. 1, pp. 100003-100003
Closed Access
Swetha Reddy Allamreddy, Meenakshi Arora, Raghu Ganugula, et al.
Pharmacological Reviews (2024) Vol. 77, Iss. 1, pp. 100003-100003
Closed Access
Simplicity: The Ultimate Sophistication in Managing Type 2 Diabetes With Severe Hyperglycemia
Liehua Liu, Yanbing Li
Journal of Diabetes (2024) Vol. 16, Iss. 12
Open Access
Liehua Liu, Yanbing Li
Journal of Diabetes (2024) Vol. 16, Iss. 12
Open Access
Personalized approach for type 2 diabetes pharmacotherapy: where are we and where do we need to be?
Muhammad Abdul‐Ghani, Ralph A. DeFronzo
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 16, pp. 2113-2125
Closed Access | Times Cited: 3
Muhammad Abdul‐Ghani, Ralph A. DeFronzo
Expert Opinion on Pharmacotherapy (2021) Vol. 22, Iss. 16, pp. 2113-2125
Closed Access | Times Cited: 3
Pioglitazone: Reviewed and Renewed
Maria S. Charbonneau, Kam L. Capoccia
ADCES in Practice (2022) Vol. 10, Iss. 4, pp. 30-35
Closed Access | Times Cited: 2
Maria S. Charbonneau, Kam L. Capoccia
ADCES in Practice (2022) Vol. 10, Iss. 4, pp. 30-35
Closed Access | Times Cited: 2
The world congress on insulin resistance, diabetes, and cardiovascular disease (WCIRDC )
Zachary T. Bloomgarden
Journal of Diabetes (2022) Vol. 14, Iss. 3, pp. 163-166
Open Access | Times Cited: 1
Zachary T. Bloomgarden
Journal of Diabetes (2022) Vol. 14, Iss. 3, pp. 163-166
Open Access | Times Cited: 1
Cardiovascular and renal outcomes of initial combination therapy with glucose‐lowering agents versus a stepwise approach in newly diagnosed or treatment‐naïve type 2 diabetes: A systematic review and meta‐analysis
Samuel Seidu, Abdullah Almaqhawi, Mohammad Abdool, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 8, pp. 1469-1482
Open Access | Times Cited: 1
Samuel Seidu, Abdullah Almaqhawi, Mohammad Abdool, et al.
Diabetes Obesity and Metabolism (2022) Vol. 24, Iss. 8, pp. 1469-1482
Open Access | Times Cited: 1
Initiale Kombitherapie: Pro & Kontra
Thomas Meißner
Info Diabetologie (2023) Vol. 17, Iss. 4, pp. 56-56
Closed Access
Thomas Meißner
Info Diabetologie (2023) Vol. 17, Iss. 4, pp. 56-56
Closed Access
Acute pharmacodynamic responses to sitagliptin: Drug-induced increase in early insulin secretion in oral glucose tolerance test
A L Beitelshees, Elizabeth A. Streeten, Zhinous Shahidzadeh Yazdi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
A L Beitelshees, Elizabeth A. Streeten, Zhinous Shahidzadeh Yazdi, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
AWARE. A web application to rapidly assess cardiovascular risk in Type 2 Diabetes Mellitus.
Cesare Berra, Roberto Manfrini, Marco Mirani, et al.
Research Square (Research Square) (2022)
Open Access
Cesare Berra, Roberto Manfrini, Marco Mirani, et al.
Research Square (Research Square) (2022)
Open Access
AWARE. A web application to rapidly assess cardiovascular risk in Type 2 Diabetes Mellitus.
Cesare Berra, Roberto Manfrini, Marco Mirani, et al.
Research Square (Research Square) (2022)
Open Access
Cesare Berra, Roberto Manfrini, Marco Mirani, et al.
Research Square (Research Square) (2022)
Open Access
